Tag Archives: Next Generation Sequencing

At the heart of the sequencing debate…lies Ingenuity Variant Analysis

Whether you use whole genome or whole exome technologies, the next-generation sequencing industry continues to face the difficult task of relating NGS data back to affected biology.   Ingenuity Variant Analysis solves this problem by allowing researchers to identify causal … Read More

Posted in Ingenuity Partners, Ingenuity Variant Analysis, News, NGS | Tagged , , , , , , , , , , ,

Free whitepaper: Integrated RNA-Seq Data Analysis Pipeline – Generating Evidence-Backed Hypotheses in Silico

Download the free white paper from Ingenuity to see how IPA and CLC bio can help with in silico analysis of RNA-Seq data to identify patient-specific prostate cancer mechanisms, potential biomarkers, and to generate evidence-backed hypotheses. You can also register … Read More

Posted in Biomarkers, Customer Resources, Hypothesis Generation, Ingenuity Partners, IPA Training, Neuroscience, NGS, Oncology, RNA-Seq | Tagged , , , , , , , , ,